Patients with an AFP value ≥ 20 ng/mL showed an increased risk of developing HCC metastases over time compared with patients with AFP < 20 ng/mL (HR 3.5; 95%CI 1.6–7.8; p = 0.002). This evidence concerns the gene AFP and hepatocellular carcinoma.